Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors
- PMID: 12573616
- DOI: 10.1016/s1525-0016(02)00017-5
Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors
Abstract
Tissue macrophages, in particular hepatic Kupffer cells (KCs), contribute to early inflammatory responses following adenoviral vector administration. This study evaluates the effect of selective and transient (3 days) depletion of KCs by a single injection of clodronate liposomes on the in vivo performance of high-capacity adenoviral (HC-Ad) vectors. In KC-depleted C57BL/6 and C3H mice increased and stabilized hAAT levels were observed following intravenous injection of HC-Ad vectors expressing human alpha-1 anti-trypsin (hAAT) either from the hAAT promoter or from the human cytomegalovirus promoter. Comparable increases in hAAT levels were obtained in mice preinjected with a transcriptionally silent HC-Ad vector. Interestingly, in the majority of animals of both strains depletion of KCs was sufficient to prevent the generation of anti-hAAT antibodies, resulting in prolonged transgene expression. Thus, short-term and selective depletion of hepatic macrophages at the same time significantly increased hepatic transgene expression and reduced the humoral immune response to the transgenic protein.
Similar articles
-
Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors.Hum Gene Ther. 1999 Jul 20;10(11):1773-81. doi: 10.1089/10430349950017455. Hum Gene Ther. 1999. PMID: 10446917
-
Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors.Hum Gene Ther. 1997 Jul 1;8(10):1275-86. doi: 10.1089/hum.1997.8.10-1275. Hum Gene Ther. 1997. PMID: 9215744
-
Transient depletion of specific immune cell populations to improve adenovirus-mediated transgene expression in the liver.Liver Int. 2015 Apr;35(4):1274-89. doi: 10.1111/liv.12571. Epub 2014 May 10. Liver Int. 2015. PMID: 24754307
-
Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.Gene Ther. 2002 Nov;9(22):1520-8. doi: 10.1038/sj.gt.3301824. Gene Ther. 2002. PMID: 12407424
-
Variables affecting in vivo performance of high-capacity adenovirus vectors.J Virol. 2002 Feb;76(4):1600-9. doi: 10.1128/jvi.76.4.1600-1609.2002. J Virol. 2002. PMID: 11799154 Free PMC article.
Cited by
-
The role of liver sinusoidal cells in hepatocyte-directed gene transfer.Am J Pathol. 2010 Jan;176(1):14-21. doi: 10.2353/ajpath.2010.090136. Epub 2009 Nov 30. Am J Pathol. 2010. PMID: 19948827 Free PMC article. Review.
-
The liver as a target organ for gene therapy: state of the art, challenges, and future perspectives.Pharmaceuticals (Basel). 2012 Dec 10;5(12):1372-92. doi: 10.3390/ph5121372. Pharmaceuticals (Basel). 2012. PMID: 24281341 Free PMC article.
-
Helper-dependent adenoviral vectors for liver-directed gene therapy of primary hyperoxaluria type 1.Gene Ther. 2016 Feb;23(2):129-34. doi: 10.1038/gt.2015.107. Epub 2015 Dec 24. Gene Ther. 2016. PMID: 26609667 Free PMC article.
-
Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model.Gene Ther. 2015 Sep;22(9):696-706. doi: 10.1038/gt.2015.45. Epub 2015 May 4. Gene Ther. 2015. PMID: 25938192
-
Liver-directed gene therapy for dyslipidemia and diabetes.Curr Atheroscler Rep. 2004 May;6(3):203-9. doi: 10.1007/s11883-004-0033-6. Curr Atheroscler Rep. 2004. PMID: 15068745 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources